公司概覽
業務類別 --
業務概覽 Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements to fund the further development of its products. It has one segment, the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
公司地址 885, Avenue Eugene Avinee, Parc Eurasante, Loos, FRA, 59120
電話號碼 +33 320164000
傳真號碼 +33 220164001
公司網頁 https://www.genfit.com
員工數量 192
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
沒有相關資料。
 
董事會成員
董事會 職務 更新日期
Mr. Jean-Francois Tine Independent Director 03/04/2026
Mr. Tristan Imbert Independent Director 03/04/2026
Ms. Sandra Silvestri Director 03/04/2026
Ms. Anne-Helene Monsellato Independent Director 03/04/2026
Dr. Catherine Larue, PhD Independent Director 03/04/2026
Ms. Katherine Bach Kalin, M.B.A. Independent Director 03/04/2026
Mr. Eric Baclet Vice-Chairman of the Board 03/04/2026
Mr. Jean-Francois Mouney Chairman of the Board 03/04/2026
Mr. Philippe Moons Independent Director 03/04/2026
Mr. John Brozek Director 03/04/2026
 
所屬ETF (更新日期: 30/05/2026 02:07)
代號 名稱 佔比% 持有日期
AVDSAvantis International Small Cp Eq ETF0.01%30/04/2026
AVSDAvantis Responsible International Eq ETF0.001%30/04/2026
DFISDimensional International Small Cap ETF<0.000001%27/02/2026
DXIVDimensional International Vector Eq ETF<0.000001%07/10/2025
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.